Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trial of Antihypertensive Intervention Management
NCT00000513Phase 3Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Apr 1984
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of atenolol, chlorthalidone in hypertension (HTN), sponsored by National Heart, Lung, and Blood Institute. Started Apr 1984; status: completed.
02
Drugs
atenololchlorthalidone
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00000513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000513.